Ted Williams
Chief Tech/Sci/R&D Officer at Tissue Repair Co.
Profile
Mr. Ted Williams is VP-Manufacturing & Technical Operations at Tissue Repair Co. and VP-Manufacturing & Technical Operations at Taxus Cardium Pharmaceuticals Group, Inc.
Mr. Williams was previously employed as VP-Manufacturing & Technical Operations by InnerCool Therapies, Inc., a Director-Research Operations by Collateral Therapeutics, Inc., Senior Manager-Quality Systems by Advanced Tissue Sciences, Inc., a Manager-Quality Control by Chiron Technologies Pty Ltd, Supervisor-Quality Control by Viagene, Inc., Chief Micro Biologist by Yuma Regional Medical Center, Inc., and Senior Director-Quality Control by Favrille, Inc.
He received his undergraduate degree from Weber State University.
Ted Williams active positions
| Companies | Position | Start |
|---|---|---|
Tissue Repair Co.
 Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Chief Tech/Sci/R&D Officer | 01/08/2006 |
Former positions of Ted Williams
| Companies | Position | End |
|---|---|---|
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/07/2009 |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/2004 |
| Advanced Tissue Sciences, Inc. | Corporate Officer/Principal | 01/01/2001 |
Chiron Technologies Pty Ltd
 Chiron Technologies Pty Ltd BiotechnologyHealth Technology Part of Global Gaming Technologies Corp., Chiron Technologies Pty Ltd is involved in biopharmaceuticals, blood testing and vaccines. Chiron Technologies was acquired by MitoKor, Inc. from Chiron Corp. on February 09, 2000. | Corporate Officer/Principal | 01/01/1998 |
Chiron Viagene, Inc.
 Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Corporate Officer/Principal | 01/01/1995 |
Training of Ted Williams
| Weber State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
| Advanced Tissue Sciences, Inc. | Commercial Services |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Collateral Therapeutics, Inc. focuses on the discovery and development of non-surgical gene therapy product candidates for the potential treatment of cardiovascular diseases including: coronary artery disease; peripheral vascular disease; restenosis; congestive heart failure and heart attack. The company's core technology is centered on methods of cardiovascular gene therapy; a portfolio of therapeutic genes and gene delivery vectors. Its portfolio includes human genes in the Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) gene families to be used in investigational gene therapy product candidates. The company is headquartered in San Diego, CA. | Commercial Services |
| Favrille, Inc. | Health Technology |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
Chiron Technologies Pty Ltd
Chiron Technologies Pty Ltd BiotechnologyHealth Technology Part of Global Gaming Technologies Corp., Chiron Technologies Pty Ltd is involved in biopharmaceuticals, blood testing and vaccines. Chiron Technologies was acquired by MitoKor, Inc. from Chiron Corp. on February 09, 2000. | Health Technology |
Chiron Viagene, Inc.
Chiron Viagene, Inc. Miscellaneous Commercial ServicesCommercial Services Chiron Viagene, Inc. provides technical services and life science research. The company is based in San Diego, CA. The company specializes in EMSA reagents and services, as well as producing innovative technology. The company was founded by Paul K. Laikind, David F. Hale, Jack W. Reich, Harry E. Gruber. Chiron Viagene was acquired by Chiron Corp. on October 03, 1995 for $135 million. | Commercial Services |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
Yuma Regional Medical Center, Inc.
 Yuma Regional Medical Center, Inc. Hospital/Nursing ManagementHealth Services Yuma Regional Medical Center, Inc. owns and operates hospitals. Its medical services include allergy, asthma and immunology, cancer care, imaging and radiology, eye care, clinical trials, rehabilitative services, surgery, orthopaedics, weight loss surgery and women’s health. The company was founded in 1958 and is headquartered in Yuma, AZ. | Health Services |
- Stock Market
- Insiders
- Ted Williams
